Phase Ia trial of RVX 208 in volunteers.

Trial Profile

Phase Ia trial of RVX 208 in volunteers.

Phase of Trial: Phase I

Latest Information Update: 31 Mar 2009

At a glance

  • Drugs Apabetalone (Primary)
  • Indications Acute coronary syndromes; Alzheimer's disease; Atherosclerosis; Low HDL cholesterol
  • Focus Adverse reactions
  • Most Recent Events

    • 31 Mar 2009 Results presented at ACC 2009.
    • 10 Nov 2008 Results presented at AHA 2008.
    • 10 Nov 2008 Resverlogix has reported positive results of an exploratory analysis of effects on amyloid-beta levels.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top